Quant Genius Billionaire Jim Simons’ Top 10 Stock Picks
In this article we take a look at billionaire Jim Simons' top 10 stock picks.
Posts Tagged ‘NYSE:NVO’
Billionaire Jim Simons’ Top 5 Stock Picks
In this article, we discuss billionaire Jim Simons' top 5 stock picks.
Is NVO A Good Stock To Buy?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Novo Nordisk A/S (NVO): Hedge Funds In Wait-and-See Mode
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
15 States With The Highest Diabetes Rates In U.S.
In this article, we present the 15 states with the highest diabetes rates in the U.S. Click to skip ahead and see the 5 states with the highest diabetes rates in the US.
Did Hedge Funds Make The Right Call On Novo Nordisk A/S (NVO)?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Is Novo Nordisk (NVO) a Smart Long-term Buy?
Saturna Capital Corporation is the investment management company of Sextant Mutual Funds.
Before You Buy Novo Nordisk (NVO) Stock, Read This
Amana Mutual Funds Trust recently released its Q1 2020 Investor Letter, a copy of which you can download here.
Here is What Hedge Funds Think About Novo Nordisk A/S (NVO)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Were Hedge Funds Right About Buying Novo Nordisk A/S (NVO)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Are Buying Novo Nordisk A/S (NVO)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Novo Nordisk A/S (NVO) A Good Stock To Buy?
Is Novo Nordisk A/S (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before conducting days of in-depth research.
Novo Nordisk A/S (NVO): Hedge Funds Are Snapping Up
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and ...
Here is What Hedge Funds Think About Novo Nordisk A/S (NVO)
Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap...
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher.
30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
10 Least Obese Countries in the World
The 10 least obese countries in the world are mostly from Asia and Africa.
Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors
Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma name.
11 Fattest Countries in The World
The problem of obesity is a modern one, with large sections of the global population becoming overweight late in the 20th century and into the 21st, and the prevalence is especially...
Sanofi SA (ADR) (SNY) Files Suit Against Novo Nordisk A/S (ADR) (NVO) Over False Insulin Claims
Novo Nordisk A/S (ADR) (NYSE:NVO) has been sued by Sanofi SA (ADR) (NYSE:SNY) for making false claims.
10 Largest Hedge Funds in The World And Their Favorite Stock Picks
Which are the largest hedge funds in the world? Most investors see hedge fund size as an indication of investment success.
Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up
After several tireless days we have finished crunching the numbers from the more than 700 13F filings issued by the successful hedge funds and other investment firms that we track...
US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6
The US Food and Drug Administration (FDA) has recently approved the Soliqua 100/33 (insulin glargine and lixisenatide injection) of Sanofi SA (ADR) (NYSE:SNY) and the Xultophy...
10 Most Successful Investors in the World
These 10 most successful investors in the world don’t have much in common aside from their obscene net worths.
Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers
Novo Nordisk A/S (ADR) (NYSE:NVO) incoming President and CEO Lars Fruergaard Jørgensen is slated to start his leadership roles in the New Year.
Top Performing CEOs in the World and What Top Performing Hedge Funds Think of Their Companies
It is hard to be the CEO of a company these days given the increasing political uncertainty and slow growth being faced by major developed economies.
5 Most Successful Quant Hedge Funds And Their Top Picks
The prominence of quantitative hedge funds in the alternative asset management space has increased exponentially since the turn of the century, with several of them now considered...
Two Dividend Growth Stocks on My Radar
In the past few days, I have noticed that a couple of dividend growth stocks have been selling at lower prices than before.
American Express Company (AXP), Rockwell Collins Inc. (COL) & More: Here’s Why These Stocks Are Trending Today
Markets shrugged off the negative trend and are trading well in the green today amid news that World Trade Organization’s has slashed its world trade forecast to the lowest...
Inside the FDA: Why Sanofi SA (ADR) (SNY) IGlarLixi Was Delayed But Novo Nordisk A/S (ADR) (NVO) IDegLira Wasn’t
Update: Several hours after the initial publication of this report on September 2, Novo Nordisk announced that the FDA has extended the regulatory review for IDeglira, with...
VeriFone (PAY), Gilead (GILD) Among 5 Stocks That Hit 52-Week Lows Last Week
In this article we'll take a look at why VeriFone Systems Inc (NYSE:PAY), Dynavax Technologies Corporation (NASDAQ:DVAX), Gilead Sciences, Inc.
The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NVO) vs Oramed Pharmaceuticals, Inc. (ORMP)
The problem with being at the top of one of the largest healthcare market niches in the world is extremely heightened expectations.
As Old Bestsellers Plateau, a Look at 4 Next Generation Diabetes Drugs
In part I of our comprehensive report on the type II diabetes market, we broke down the top 4 best selling diabetes drugs, their prospects and the companies behind them.
The Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
At the turn of the millennium, the population of the United States clocked in at 282.2 million.
Renaissance Technologies Bullish on PepsiCo (PEP) and Gold Heading Into Q2
Founded in 1982 by James ‘Jim’ Simons, Renaissance Technologies employs quantitative models based on mathematical and statistical analysis to make its stock selections and...
Is Novo Nordisk A/S (ADR) (NVO) Going to Burn These Hedge Funds?
Is Novo Nordisk A/S (ADR) (NYSE:NVO) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Multi-Billion-Dollar Fund Renaissance Technologies Entered Q4 With These Top Picks
Well-known hedge fund Renaissance Technologies LLC needs little or no introduction at all.
Arrowstreet Capital Goes Heavily Bullish & Bets Big on These Stocks in Q4
Arrowstreet Capital is a Boston, Massachusetts-based quantitative hedge fund founded by Peter Rathjens, Bruce Clarke and John Campbell in 1999.
Billionaire Ken Fisher’s Top Healthcare Stock Picks
At the beginning of September, when the U.S stock markets were in turmoil, Ken Fisher of Fisher Asset Management asserted that the August correction would be “over just as fast...
New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR) (NVO)
On October 15, Emisphere Technologies Inc.
Not Even Jim Simons’ Mathematical Models Could Pick Winning Stocks In Q3
Renaissance Technologies, led by Jim Simons, disclosed a total of 3,196 positions in its latest 13F filing for the reporting period of June 30.
This is What Hedge Funds Have to Say about Two Healthcare Stocks on the Move
Novo Nordisk A/S (ADR) (NYSE:NVO) and Sanofi SA (ADR) (NYSE:SNY) are two healthcare companies that recently received product approval in the US and Europe, respectively, but both...
Billionaire Jim Simons’ Top Holdings: Amazon.com Inc. (AMZN), Colgate-Palmolive Company and More
Renaissance Technologies, founded by billionaire Jim Simons, has filed its latest 13F with the U.S.
UnitedHealth Group (UNH), Novo Nordisk (NVO), Johnson & Johnson (JNJ): Cheapest Healthcare Stocks Picked By Markel Gayner
Tom Gayner’s Markel Gayner Asset Management, the investment division of financial holding company Markel Corporation (NYSE:MKL), has filed its latest 13F with the Securities...
Hedge Funds Made A Bundle By Betting On Amazon.com, Inc. (AMZN), Apple, and Pfizer Inc
As we are entering into the second quarter of 2015, it's time to take a brief look back and see how the market performed during the first three months of the year, and most importantly...
Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons’ Holdings for Long-Run
The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible for prompting other...
McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO), Colgate-Palmolive Company (CL): A Look At Jim Simons’ Top Picks for the Second Quarter
Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one of the best performing...
Renaissance Technologies Loves These Stocks: McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO) & Others
In the latest 13F, Renaissance Technologies, previously managed by Jim Simons, revealed its holding for the fourth quarter of 2013.
Nektar Therapeutics (NKTR), Pfizer Inc. (PFE): What’s MannKind Corporation (MNKD) Really Worth?
This is close to the market cap that Bank of America's Steve Byrne thinks MannKind Corporation (NASDAQ:MNKD) is worth.
Goldman Sachs Group, Inc. (GS), Novo Nordisk A/S (ADR) (NVO), Seaspan Corporation (SSW): Five Stocks Growing Their Dividends by 25% Per Year
Dividend investors would be wise to focus not just on a stock's current yield, but also on the long-term growth potential of its dividends.
